Search results for: Pricing and Reimbursement
Filter search results
European Medicines Pricing and Reimbursement: Now and the Future
1 January 2007
…and reimbursement policies in Germany: current and future trends; Pricing and reimbursement policies in UK: a current and future trends; Pricing and reimbursement policies in Italy: current and future trends;…
Evidence on Valued Based Pricing and Reimbursement Schemes
30 September 2011
…and performance-based reimbursement. Dr. Mestre-Ferrandiz Despite the potential importance of value-based schemes for influencing the pricing, reimbursement and use of pharmaceuticals, the literature contains remarkably little hard evidence about their…
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…shortages, policymakers should recognise the value of supply diversification, effective market competition, and supply-chain resilience, supported by incentives at regulatory, health technology assessment, and pricing and reimbursement levels. The Dynamics…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
…regulatory pathways to support timely access to promising therapies in areas of high unmet medical need. On the other hand, Health Technology Assessment (HTA) and pricing and reimbursement (P&R) processes…
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
…practices should be shared and that, to seize opportunities, companies should monitor and respond to public sentiment, proactively address any negative issues, and invest in R&D and technology to deal…
Delivering the Triple Win: A Value-Based Approach to Pricing
20 April 2023
…sustainable, and the innovation pipeline is robust. In this report, we investigate the theory and practice of value-based pricing in the pharmaceuticals industry, and provide recommendations for how implementation of…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…introducing effective HTA and related priority setting mechanisms in order to support both the introduction of universal health care and more efficient pricing and reimbursement mechanisms based on value-based pricing….
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…Pay for something else and you will get something else. Hence my motivation in writing and arguing for value-based pricing as a means of putting the static and dynamic pieces…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…be low. Benefits and weaknesses of TEVs and of the European Commission’s proposals The TEV proposal has been controversial and we set out the arguments for and against drawing on…